Supernus Pharmaceuticals, Inc. (SUPN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$52.27
Day's range
$54.3

Supernus Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 9.35 M $434.87 M   6.28% 16.10%
MILLENNIUM MANAGEMENT LLC 08/14/2026 3.85 M $179.21 M   16.20% 6.64%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 3.31 M $153.74 M   2.06% 5.69%
ARMISTICE CAPITAL, LLC 08/14/2026 2.65 M $123.07 M   39.62% 4.56%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.52 M $117.05 M   2.01% 4.33%
STATE STREET CORP 08/07/2026 2.46 M $114.41 M   7.50% 4.24%
MACQUARIE MANAGEMENT HOLDINGS, INC. 08/14/2026 2.38 M $110.62 M   16.74% 4.10%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 2.08 M $96.65 M   -9.92% 3.58%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.57 M $73.04 M   -3.29% 2.70%
STEPHENS INVESTMENT MANAGEMENT GROUP LLC 07/29/2026 1.49 M $69.11 M   9.95% 2.56%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.48 M $68.75 M   -13.31% 2.55%
LOOMIS SAYLES & CO L P 08/14/2026 1.48 M $68.61 M   3.47% 2.54%
CITADEL ADVISORS LLC 09/02/2026 1.37 M $63.90 M   -8.00% 2.37%
TWO SIGMA INVESTMENTS, LP 08/14/2026 1.18 M $55.09 M   336.67% 2.04%
GW&K INVESTMENT MANAGEMENT, LLC 08/12/2026 1.04 M $48.24 M   -1.70% 1.79%
SOFINNOVA INVESTMENTS, INC. 08/14/2026 1.04 M $48.20 M   8.59% 1.78%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 922.17 K $42.89 M   85.10% 1.59%
MORGAN STANLEY 08/13/2026 876.84 K $40.78 M   -4.05% 1.51%
GOLDMAN SACHS GROUP INC 08/14/2026 819.43 K $38.11 M   -4.33% 1.41%
D. E. SHAW & CO., INC. 08/14/2026 767.67 K $35.70 M   23.33% 1.32%
NORTHERN TRUST CORP 08/13/2026 733.37 K $34.11 M   4.85% 1.26%
WOODLINE PARTNERS LP 08/14/2026 708.28 K $32.94 M   57.75% 1.22%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 703.55 K $32.72 M   -0.34% 1.21%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 703.55 K $32.72 M   100.00% 1.21%
BANK OF AMERICA CORP /DE/ 08/14/2026 621.10 K $28.89 M   -13.04% 1.07%
ASHFORD CAPITAL MANAGEMENT INC 08/21/2026 613.78 K $28.55 M   -4.90% 1.06%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 520.00 K $24.19 M   100.00% 0.90%
RICE HALL JAMES & ASSOCIATES, LLC 08/07/2026 490.22 K $22.80 M   2.68% 0.84%
SYSTEMATIC FINANCIAL MANAGEMENT LP 08/14/2026 474.13 K $22.05 M   26.07% 0.82%
ABRDN PLC 07/31/2026 453.21 K $21.08 M   64.47% 0.78%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 432.48 K $20.24 M   -4.06% 0.74%
INVESCO LTD. 08/14/2026 395.10 K $18.38 M   -4.26% 0.68%
VICTORY CAPITAL MANAGEMENT INC 08/07/2026 391.08 K $18.19 M   -22.16% 0.67%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 384.83 K $17.90 M   4.22% 0.66%
BANK OF NEW YORK MELLON CORP 08/06/2026 377.40 K $17.55 M   4.14% 0.65%
SCHRODER INVESTMENT MANAGEMENT GROUP 08/13/2026 368.02 K $17.22 M   109.01% 0.63%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 348.46 K $16.21 M   2.15% 0.60%
FREESTONE GROVE PARTNERS LP 08/14/2026 316.40 K $14.72 M   -50.66% 0.54%
FMR LLC 08/13/2026 309.09 K $14.38 M   47.63% 0.53%
KRENSAVAGE ASSET MANAGEMENT, LLC 08/14/2026 280.68 K $13.05 M   0.00% 0.48%
JPMORGAN CHASE & CO 08/12/2026 272.33 K $12.86 M   8.61% 0.47%
NUVEEN, LLC 08/11/2026 262.68 K $12.22 M   21.58% 0.45%
UBS GROUP AG 08/13/2026 220.46 K $10.25 M   5.42% 0.38%
GLENMEDE TRUST CO NA 08/10/2026 210.95 K $9.81 M   -3.72% 0.36%
PUBLIC SECTOR PENSION INVESTMENT BOARD 08/13/2026 199.35 K $9.27 M   -2.83% 0.34%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 08/11/2026 182.91 K $8.51 M   100.00% 0.32%
AMERIPRISE FINANCIAL INC 08/14/2026 171.53 K $7.98 M   -1.37% 0.30%
ARISTOTLE CAPITAL BOSTON, LLC 08/14/2026 169.69 K $7.89 M   -16.45% 0.29%
AMERICAN CENTURY COMPANIES INC 08/12/2026 160.13 K $7.45 M   -0.56% 0.28%
MAN GROUP PLC 08/14/2026 156.42 K $7.28 M   108.58% 0.27%

Supernus Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 496 institutional investors and hedge funds held shares of Supernus Pharmaceuticals Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 9.35 M

MILLENNIUM MANAGEMENT LLC: 3.85 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 3.31 M

ARMISTICE CAPITAL, LLC: 2.65 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.52 M

STATE STREET CORP: 2.46 M

105.03% of Supernus Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 90.81 M shares in the last 24 months. This purchase volume represents approximately $4.92 B in transactions.